Journal of Cardiovascular Electrophysiology

Article	Citations
Long conduction time from the anterior left atrium to coronary sinus during entrainment pacing of a bi‐atrial tachycardia: What is the mechanism?	92
Bringing big data to vascular complications during atrial fibrillation ablation	53
Reply to reply to S‐ICD: Is it time for radiological follow‐ups? by Bisignani et al	52
Comments on impact of obesity on acute complications of catheter ablation for cardiac arrhythmia	49
Pulmonary vein reconnection and repeat ablation characteristics following cryoballoon‐ compared to radiofrequency‐based pulmonary vein isolation	46
Outcomes of leadless pacemaker implantation in patients with mechanical heart valves	43
Potential advantages of the KODEX‐EPD system as the fourth 3D mapping system for atrial fibrillation ablation	41
Ready to deploy prophylactics?	39
The high‐density grid catheter: A safe adjunctive tool in pediatric and complex congenital heart disease patients	38
Focal and rotational drivers in persistent atrial fibrillation: Are we chasing ghosts?	35
Short or long‐coupled idiopathic ventricular fibrillation: Does the coupling interval really matter?	32
Medical cardioversion of atrial fibrillation and flutter with class IC antiarrhythmic drugs in young patients with and without congenital heart disease	31
Pacemaker‐mediated reentrant arrhythmia facilitated by an atrial‐tracking leadless pacemaker	31
An irregular tachycardia: What is the mechanism?	29
Radiofrequency ablation of persistent atrial fibrillation in a patient with situs inversus totalis and interrupted inferior vena cava	29
Letter to the Editor regarding: Impact of artificial intelligence arrhythmia mapping on time to first ablation, procedure duration, and fluoroscopy use	29
Issue Information	28
Targeted ablation of residual pulmonary vein potentials in atrial fibrillation ablation through ultra‐high‐density mapping: Insights from the CHARISMA registry	28
Step‐by‐step recommendations utilizing four‐dimensional intracardiac echocardiography in left atrial appendage procedures	27
Physiological pacing with conduction system capture: How to confirm bundle capture in clinical practice	26
	26
Regarding the article “automatic identification of ablation targets in persistent atrial fibrillation: Initial experience with a new mapping tool”	26
Central venus cannulation during cardiac surgery as a possible new additional risk factor for late post‐operative atrial fibrillation insurgence	26
Comments on “High Power Short Duration Temperature‐Controlled Radiofrequency Ablation for the Treatment of Outflow Tract Ventricular Arrhythmias”	25
Accessory Pathway Antegrade Electrophysiologic Features Among Wolff–Parkinson–White Patients: The Risk in Relation to the Location	25

A Case of Ventricular Premature Contractions With Multiple Morphologies Reproduced by a Single Ventricular Extrastimulus With Different Coupling Intervals	25
A 15‐year follow‐up study of radiofrequency catheter ablation for atrial fibrillation in patients with tachycardia‐bradycardia syndrome	25
Is there a need for a novel algorithm for accessory pathways localization?	25
Clinical relevance of the blanking period on late recurrence after catheter ablation of atrial fibrillation	25
“When Propensity Score Does Not Always Match?” by Antoine Da Costa et al., Based on “J. Hirokami, K. R. J. Chun, S. Bordignon, et al., Pulsed Field Ablation for Persistent Atrial Fibrillation in EU‐PO	24
Ultrasound‐guided vascular access for CIED implantation: A step‐by‐step guide	23
Electrical storm after left ventricular assist device (LVAD) implantation	23
Reconsider the Indication of Implantable Cardioverter Defibrillator in Patients With Cardiac Amyloidosis	22
Multielectrode Radiofrequency Balloon Catheter for Paroxysmal Atrial Fibrillation: Results From the Global, Multicenter, STELLAR Study	22
Novel streamlined technique for left atrial appendage closure using a radiofrequency wire‐based large access system	22
Narrow complex tachycardia with alternating atrial activation: What is the mechanism?	21
The Single‐Delayed‐Phase Contrast Computed Tomography Before Ablation to Reduce Radiation Exposure Without Compromising Diagnostic Pulmonary Vein Accuracy	21
First clinical data on artificial intelligence‐guided catheter ablation in long‐standing persistent atrial fibrillation	21
Sotalol in neonates for arrhythmias: Dosing, safety, and efficacy	21
Age, Frailty, and Outcomes After Atrial Fibrillation Ablation: A Nationwide Cohort Study	20
Long‐Term Impact of GLP‐1 Receptor Agonists on AF Recurrence After Ablation in Obese Patients	20
Atrial fibrillation incidence, prevalence, predictors, and adverse outcomes in acute coronary syndromes: A pooled analysis of data from 8 million patients	20
Incidence and Predictors of Pacing‐Induced Cardiomyopathy in Paced Patients Undergoing Attempted Left Bundle Branch Area Pacing	20
A 10 J shock impedance in sinus rhythm correlates with a 65 J defibrillation impedance during subcutaneous defibrillator implantation using an intermuscular technique	20
“Pill‐in‐Pocket” anticoagulation for stroke prevention in atrial fibrillation	19
Evaluation of microembolic signals on carotid ultrasound during pulmonary vein isolation with high‐power short‐duration and cryoballoon ablations: When and where do bubble and solid emboli arise?	19
Ablation of atrial fibrillation beyond pulmonary vein isolation: Do additional ablation lesions impact left atrial function?	19
Elevated fibrosis burden as assessed by MRI predicts cryoballoon ablation failure	19
Corrigendum	19
	18
Lesion monitoring parameters as predictors of atrial arrhythmia recurrence after catheter ablation in persistent AF: A DECAAF II sub‐analysis	18
Characteristics of successful reactive atrial‐based antitachycardia pacing in patients with cardiac implantable electronic devices: History of catheter ablation of atrial fibrillation as a predictor o	18
The Association Between Newly Acquired Permanent Left Bundle Branch Block Following Transcatheter Aortic Valve Replacement and New‐Onset Cardiomyopathy	18
	18
Impact of left atrial low‐voltage areas during initial ablation procedures on very late recurrence of atrial fibrillation	18
Left Atrial Function and Strain Assessed by Three‐Dimensional Echocardiography as Factors Associated With Atrial Fibrillation Recurrence After Pulmonary Vein Ablation	18
In which patients with heart failure should ablation of atrial fibrillation not be performed?	18
Temporary Restoration of Sinus Rhythm Improves Outcomes of Catheter Ablation for Longstanding Persistent Atrial Fibrillation	18
Practical and systematic approach using the steerable catheter and stylet‐driven lead to deliver safe and effective left bundle branch area pacing	18
Impact of remote reprogramming on insertable cardiac monitors alert burden	17
Ventricular arrhythmias in patients with bicuspid aortic valves	17
	17
Feasibility of a novel atrial mechanical sensing method for leadless atrioventricular synchronous pacing	17
Impact of omitting the intravenous heparin bolus on outcomes of leadless pacemaker implantation	16
Reply to: “Seize the day….s(e)ize the device: The emerging imaging modality to improve left atrial appendage device sizing”	16
Simultaneous narrow and wide QRS complex tachycardia: Misdiagnosis or missed diagnosis?	16
Authors' response to letter to the editor regarding relationship between sodium‐glucose cotransporter two inhibitors and atrial fibrillation recurrence after pulmonary vein isolation in patients with	16
Convergent ablation for persistent atrial fibrillation: A UK multicentre perspective	16
Treating syncope without drugs: Standing still, exercising hard, or simply the “expert's touch”?	16
The clock is ticking for cryoablation as treatment option for atrial fibrillation	16
Will the insulated‐tip radiofrequency catheter transform ablation procedures?	16
Temporal and spatial pacemap parameters for identification of cardiac surfaces with critical sites for ventricular tachycardia	16
Removal of an active fixation coronary sinus pacing lead 5 years postimplant: A case report	15
COVID‐19 vaccination and atrial fibrillation: When pandemics collide	15
Costs, efficiency, and patient‐reported outcomes associated with suture‐mediated percutaneous closure for atrial fibrillation ablation: Secondary analysis of a randomized clinical trial	15

Visualization of Electrophysiologically Defined Superior Vena Cava‐Right Atrium Junction With High‐Resolution Mapping Using Atrial Extrastimulus	15
Correction to “Comparison of treatment outcomes between convergent procedure and catheter ablation for paroxysmal atrial fibrillation evaluated with implantable loop recorder monitoring”	15
Predicting ventricular arrhythmia inducibility in ajmaline‐induced Brugada type I pattern: Validation of the dST‐Tiso interval	15
Impedance‐decline‐guide power control long application time bipolar radiofrequency catheter ablation	15
Issue Information	15
Nonlinear Relationship Between Left Atrial Volume Measured by Computed Tomography and Recurrent Atrial Arrhythmias in Patients Undergoing Catheter Ablation for Atrial Fibrillation	15
Durability of left bundle branch area pacing	15
Cardiopulmonary Exercise Testing‐Guided Beta‐Blocker Dosing in Long QT Syndrome: Genotype, Methodology, and Adherence Concerns	14
Electrogram‐based AF ablation: finally, reproducibility!	14
Leadless Versus Single Chamber Pacemakers: An Analysis From the National Readmissions Database of Adverse Outcomes	14
Same‐day discharge following catheter ablation and venous closure with VASCADE MVP: A postmarket registry	14
Irreversible electroporation for cardiac ablation: Optimizing cell type‐specific effects	14
Managing ventricular arrhythmias and implantable cardiac defibrillator shocks after left ventricular assist device implantation	14
Issue Information	14
Ventricular Tachycardia Ablation in Patients With Severely Decreased Left Ventricular Ejection Fraction	14
Right ventricular outflow tract electroanatomical abnormalities in asymptomatic and high‐risk symptomatic patients with Brugada syndrome: Evidence for a new risk stratification tool?	13
Factors Affecting the Impact of LBBBP on Ventricular Electrical Activation	13
Predictors of appropriate implantable cardiac defibrillator therapy in cardiac sarcoidosis	13
Ethanol Infusion Therapy for Incessant Atrial Tachycardia Arising From the Distal Left Atrial Appendage	13
Cost‐effectiveness of catheter ablation versus medical therapy for the treatment of atrial fibrillation in the United Kingdom	13
Acute procedural efficacy and safety of a novel cryoballoon for the treatment of paroxysmal atrial fibrillation: Results from the POLAR ICE study	13
Intermittent Ventricular Pre‐Excitation: Clinical Features and Electrophysiological Properties	13
“Function follows form”: Role of cardiac magnetic resonance for ventricular arrhythmia risk stratification in patients with cardiac sarcoidosis	13
Colchicine usage for prevention of post atrial fibrillation ablation pericarditis in patients undergoing high‐power short‐duration ablation	13
Introduction of the Low Voltage Bridge Mapping for the AVNRT RF Ablation in Children – Early Follow‐Up Results	13
Establishing electroporation thresholds for targeted cell specific cardiac ablation in a 2D culture model	13
	13
Two‐To‐One Conduction Between the Inside and Outside of the Left Atrial Posterior Wall During Atrial Tachycardia: What Is the Mechanism?	12
Is esophageal temperature management needed during cryoballoon ablation for atrial fibrillation?	12
Issue Information	12
Double atrial potentials in the coronary sinus: What is the mechanism?	12
Safety of Ablation Within the Coronary Venous Sinus in Pediatric Patients	12
Split accessory pathway potentials in a patient with antidromic AVRT	12
Editorial to: Efficacy and safety of a novel temperature‐controlled catheter for cavotricuspid isthmus ablation	12
Incidence, Predictors, and Outcomes With Ventricular Arrhythmias in Continuous Flow Left Ventricular Assist Device Recipients: A Multicenter Analysis	12
Correction to “Physiological Pacing: Historical Review With an Eye to the Future”	12
A device‐related fistula between coronary artery and left atrial appendage following left atrial appendage closure: Case presentation	12
The development of the extravascular defibrillator with substernal lead placement: A new Frontier for device‐based treatment of sudden cardiac arrest	12
Removal of EVICD Leads Are Specialized Tools Required?	12
Issue Information	11
Sensing of concealed ventricular extrasystoles by pacemakers. Fifty years later	11
Detailed mechanism of difficulty in cryoablation for atrial fibrillation in patients with very severe obesity	11
Left Atrial Wall Thickness Measured by a Machine Learning Method Predicts AF Recurrence After Pulmonary Vein Isolation	11
Conduction system pacing versus biventricular pacing: Reduced repolarization heterogeneity in addition to improved depolarization	11
Noninvasive ECG imaging of the intrinsic atrial pacemaker and atrial activation in surgically repaired or palliated congenital heart disease	11
Evaluation of a novel cardiac signal processing system for electrophysiology procedures: The PURE EP 2.0 study	11
Rationale and Design of the InsightPFA Trial: A Prospective, Multicenter, Randomized Controlled Trial of the Irreversible Electroporation‐Based Pulsed Field Ablation Versus Radiofrequency Ablation in	11
Patient reported QOL and EV‐ICD: Response to letter from Kataoka and Imamura (2024)	11
Quality of life and acceptance of the extravascular implantable cardioverter‐defibrillator	11
Impact of Sodium‐Glucose Co‐Transporter 2 Inhibitors on Atrial Fibrillation Recurrence Post‐Catheter Ablation Among Patients With Type 2 Diabetes Mellitus: A Systematic Review and Meta‐Analysis	11
Combined approach of high‐power and very high‐power, short‐duration ablation in superior vena cava isolation	11
Dilated, hypertrophic or fibrotic: On the road to a noninvasive atrial substrate classification of atrial fibrillation	11
Ventricular arrhythmias in patients with prior aortic valve intervention: Characteristics, ablation and outcomes	11
Nonclinical evaluation of chronic cardiac contractility modulation on 3D human engineered cardiac tissues	11
Exploring Optimal Cardiac Electronic Implantable Devices Programming: Reducing Non‐Actionable Alerts and Assessing Clinical Outcomes	11
Ventricular tachycardia ablation with pentaspline pulsed field technology in two patients with ischemic cardiomyopathy	11
Actual tissue temperature during ablation index‐guided high‐power short‐duration ablation versus standard ablation: Implications in terms of the efficacy and safety of atrial fibrillation ablation	11
Electrocardiographic Characteristics of Ventricular Arrhythmias Originating From High Right Ventricular Outflow Tract and Pulmonary Artery	10
Efficacy and durability of posterior wall isolation with ethanol infusion into the vein of Marshall	10
Cryoballoon for heart failure: Time to consider earlier	10
The coronary sinus Marshall structure: From an anatomical ligament to an arrhythmogenic vein	10
Urgent desensitization for severe amiodarone intolerance with a 12‐step protocol	10
Outcomes of Exclusive 50 W High Power, 5 s Ablation Close to the Esophagus in Pulmonary Vein Isolation	10
Safety aspects of very high power very short duration atrial fibrillation ablation using a modified radiofrequency RF‐generator: Single‐center experience	10
Trends in hospitalization and factors associated with in‐hospital death among pediatric admissions with implantable cardioverter defibrillators	10
Cover Image, Volume 36, Issue 8	10
Association between temperature and air pollutants with atrial fibrillation presentations to emergency departments	10
	10
Metabolic effects of the left atrial appendage exclusion (the heart hormone study)	10
Atrial Fibrillation Ablation During Hospitalization for Acute Heart Failure: Feasibility and Role of Pulsed Field Ablation	10
Surpoint algorithm for improved guidance of ablation for ventricular tachycardia (SURFIRE‐VT): A pilot study	10
Strategy for repeat procedures in patients with persistent atrial fibrillation: Systematic linear ablation with adjunctive ethanol infusion into the vein of Marshall versus electrophysiology‐guided ab	10
Leadless versus transvenous single‐chamber ventricular pacemakers: 3 year follow‐up of the Micra CED study	10
High‐Power Short‐Duration Ablation Versus Conventional Power Ablation in Pulmonary Vein Isolation in Patients With Atrial Fibrillation: An Updated Systematic Review and Meta‐Analysis of Randomized Con	10
	10
Incidental left atrial appendage isolation after catheter ablation of persistent atrial fibrillation: Mechanisms and long‐term risk of thromboembolism	10
Tricuspid valve damage and improvement following transvenous lead extraction procedures	10
Age and Clinically Actionable Events in Patients With Implantable Loop Recorders: Analysis of Multicenter Loop Recorder Registry	10
Ultrasound guidance for femoral venous access in patients undergoing pulmonary vein isolation: A quasi‐randomized study	10
Activation signatures for identifying critical isthmi of ventricular tachyarrhythmias	10

An Interesting Response During Left Bundle Branch Area Pacing: Electrophysiological Insights	10
Relationship between luminal esophageal temperature and volume of esophageal injury during RF ablation: In silico study comparing low power‐moderate duration vs. high power‐short duration	10
Efficacy and safety of the new TightRail™ mechanical sheath for transvenous lead extraction: Results of a French multicenter study	9
Machine learning identifies esophageal luminal temperature patterns associated with thermal injury in catheter ablation for atrial fibrillation	9
	9
Early ablation of newly diagnosed paroxysmal atrial fibrillation (NEWPaAF) versus newly diagnosed persistent atrial fibrillation (NEWPeAF): Comparison of patient populations and ablation outcomes	9
Leadless pacemaker implantation after lead extraction for cardiac implanted electronic device infection	9
Impact of intracardiac echocardiography usage on the safety of cryoballoon atrial fibrillation ablation: Subanalysis of the prospective FREEZE cluster cohort study	9
Mind the gap: Recurrence of ventricular pre‐excitation after accessory pathway effective refractory period with short coupled paced stimuli	9
Cover Image, Volume 32, Issue 9	9
Feasibility and Clinical Efficacy of Focal Pulsed Field Ablation in Patients With Non‐Pulmonary Vein Triggered Atrial Arrhythmia From the Superior Caval Vein	9
Widening the scope of complex cardiac implantable electronic devices implant considerations: Time for an integrated multidisciplinary approach	9
Safety of catheter ablation in obese patients: Less complicated than you think	9
Persistent phrenic nerve palsy after atrial fibrillation ablation: Follow‐up data from The Netherlands Heart Registration	9
“Piece by Piece” understanding of patient reported QOL and EV‐ICD: Response to letter from Vicentini and Rodorf	9
Electrocardiography of cardiac resynchronization therapy: Pitfalls and practical tips	9
Early and late Watchman device migration and embolization: Insights from the NCDR LAAO registry	9
Predictors of low‐voltage zones in patients with persistent atrial fibrillation eligible for catheter ablation: An observational study	9
Left atrial appendage dimension predicts elevated brain natriuretic peptide in nonvalvular atrial fibrillation. Authors response	9
Cardioneuroablation for vasovagal syncope and atrioventricular block: A step‐by‐step guide	8
Isolated JUP plakoglobin gene mutation with left ventricular fibrosis in familial arrhythmogenic right ventricular cardiomyopathy	8
Safety and durability of cavo‐tricuspid isthmus linear ablation in the current era: Single‐center 9‐year experience from 1078 procedures	8
Limitation of Unipolar Electrograms in Guiding Successful RFCA of Idiopathic Ventricular Arrhythmias Associated With Discrete Pre‐Potential	8
Transition from transesophageal echocardiography to cardiac computed tomography for the evaluation of left atrial appendage thrombus prior to atrial fibrillation ablation and incidence of cerebrovascu	8
Purkinje triggers of ventricular fibrillation in patients with hypertrophic cardiomyopathy	8
Left bundle branch area pacing using a lumenless lead: A systematic literature review and meta‐analysis	8
Issue Information	8
Endocardial Atrial Lesion Characteristics With Pentaspline Pulsed Field Ablation: Insights From Serial Mapping in Patients	8
Incidence and Characteristics of Superior Vena Cava Impact After Pulsed‐Field Ablation of the Right Pulmonary Veins	8
The advantage of the mini‐electrode‐equipped catheter for the radiofrequency ablation of paroxysmal supraventricular tachycardia	8
Outcomes of lead extraction using the TightRail™ sheath: An opportunity for increasing access while preserving outcomes?	8
Differential gap location after radiofrequency versus cryoballoon pulmonary vein isolation: Insights from a randomized trial with protocol‐mandated repeat procedure	8
Cover Image, Volume 35, Issue 12	8
Consistency of ablations with trainee and increasing independence during fellowship training—Analysis of ablation data by CARTONET	8
Issue Information	8
Issue Information	8
Quantitative assessment of transient autonomic modulation after single‐shot pulmonary vein isolation with pulsed‐field ablation	8
Abstracts from the 27th Annual International Atrial Fibrillation Symposium	8
Inflammatory reaction to TYRX antibacterial envelope mimicking infection	8
Initial clinical experience of pulmonary vein isolation using the ultra‐low temperature cryoablation catheter for patients with atrial fibrillation	8
Acute Nonsustained Mitral Isthmus Block Obtained With Sphere‐9 Lattice‐Tip Catheter Completed With Vein of Marshall Ethanol Infusion	8
Early Recurrence of Atrial Tachyarrhythmias After Pulsed Field Ablation: New Technologies, Same (Blanking) Problems	8
Six‐Month Emergent Readmissions Following Hospitalization for Atrial Fibrillation Amid the Syrian Conflict: A Real‐World Observational Cohort Study	8
Increasing time between first diagnosis of atrial fibrillation and catheter ablation adversely affects long‐term outcomes in patients with and without structural heart disease	8
Issue Information	8
Transition from two wide to a narrow QRS complex tachycardia: What is the mechanism of tachycardia and transition?	8
Efficacy of the peak frequency map for left atrial posterior wall isolation	7
Atrial fibrillation detection using insertable cardiac monitor after stroke: A real‐world cohort study	7
Long‐Term Outcomes of Cryoballoon Pulmonary Vein Isolation Freeze Using a Modified ICE‐T Protocol With a Double 120 s Applications (ICE‐T 2 × 2)	7
Association between high‐density mapping of atypical atrial flutter, clinical outcomes and healthcare utilization	7
Development of a clinically relevant ex vivo model of cardiac ablation for testing of ablation catheters	7
The impact of caffeine and taurine on ventricular arrhythmias	7
Pacing induced tricuspid regurgitation: Does the lead matter?	7
Epicardial mapping and ablation of biatrial macroreentrant tachycardia via Bachmann's bundle	7
Significance of the local largest bipolar voltage for the optimized ablation strategy using very high‐power short duration mode	7
Atrial fibrillation recurrences during the blanking period after catheter ablation with the laser balloon technique	7
Zero‐fluoroscopy ablation in patients with cardiac electronic implantable devices	7
Leadless cardiac ventricular pacing using helix fixation: Step‐by‐step guide to implantation	7
Single ring isolation for atrial fibrillation ablation: Impact of the learning curve	7
Distribution of excitation recoverable myocardium after radiofrequency ablation and its relation to energy application time and irrigation	7
Watchman device migration and embolization: A report from the NCDR LAAO Registry	7
When Close Is Not Close Enough: Cardiomyopathy After Deep Septal Pacing	7
Low voltage area guided substrate modification in nonparoxysmal atrial fibrillation: A systematic review and meta‐analysis	7
Raise‐up technique for the creation of left atrial roof lesion: A useful technique with cryoballoon for persistent atrial fibrillation	7
Effects of parameters on radiofrequency guidewire ablation: In vitro and in vivo experiments	7
Same day discharge after transvenous lead extraction: Balancing safety and efficiency	7
Successful ablation of a right concealed epicardial accessory pathway using ethanol infusion	7
The long‐term efficacy and safety of combining ablation and left atrial appendage closure: A systematic review and meta‐analysis	7
Three‐Dimensional Mapping of the Left Atrial Wall Rather Than the Left Atrial Chamber	7
RETRACTION: A Comparison of Procedure‐Related Adverse Events Between Two Right Ventricular Leadless Pacemakers	7
Initial experience with stylet‐driven versus lumenless lead delivery systems for left bundle branch area pacing	7
TEE versus ICE for LAAO: Is ICE just as nice?	7
Artificial Intelligence‐Enabled Short‐Term Ambulatory Monitoring ECG during Sinus Rhythm for Prediction of Hidden Atrial Fibrillation	7
Changing the view: Preventing pneumothorax during transvenous pacemaker implantation	7
Trends in Mortality Related to Atrial Fibrillation and Dementia in Older Adults in the United States: A 2000–2020 Analysis	7
Outcomes of vascular closure devices for femoral venous hemostasis following catheter ablation of atrial fibrillation	7
Novel methodology for the evaluation of symptoms reported by patients with newly diagnosed atrial fibrillation: Application of natural language processing to electronic medical records data	7
Left atrial epicardial adipose tissue exacerbates electrical conduction disturbance in normal‐weight patients undergoing pulmonary vein isolation for atrial fibrillation	7
Left bundle branch area pacing using a lumenless lead for LBBAP: Safety and efficacy in a new use‐case	7
A novel single shot pulsed field ablation catheter: Where does it stand and where do we go from here?	7
Pulsed Field Ablation Systems for Atrial Fibrillation	7
Challenges in cardiac implantable electronic device surveillance: Insights from real‐world data	7
The role of cardiac surgeon in transvenous lead extraction: Experience from 3462 procedures	7
Comparison of three different approaches to very high‐power short‐duration ablation using the QDOT‐MICRO catheter	7
AMEN and ALARA—Remembering the dangers of the (new) technology of lesion formation	7
	6
Sex, Race, and Socioeconomic Disparities in the Utilization of Transvenous Lead Removal for Patients Hospitalized With Cardiac Implantable Electronic Device Infections in the United States	6
Impact of Increased Cryoballoon Size on the Left Atrium, Superior Vena Cava, and Phrenic Nerve	6
Switching to exclusive remote follow‐up of CIEDs: Further proof of feasibility and safety	6
Direct Comparison of Two Commercially Available Pulsed Field Ablation Systems for Atrial Fibrillation; Procedure Characteristics and Acute Outcomes	6
Differences Between the Unipolar Versus Bipolar Potential‐Based Activation Maps of Ventricular Premature Contractions Arising From Ventricular Outflow Tracts	6
Catheter Ablation: Evolution and Efficiencies	6
Atrioventricular conduction modulation and ablation: Better at a distance from the node?	6
Reducing Unnecessary Implantable Cardioverter‐Defibrillator Therapy With ENHANCED Programming: Long‐Term Outcomes of the ENHANCED‐ICD Study	6
The effect of an initial catheter ablation with an adjunctive ethanol infusion into the vein of Marshall on persistent atrial fibrillation	6